Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asker and Baerum Cardiovascular Diabetes Study
NCT00133718Phase 4Completed
- Sponsor
- Bærum Sykehus
- Start
- Jan 2002
- Primary completion
- Apr 2006
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of metformin, repaglinide, glimepiride, pioglitazone, human insulin in type 2 diabetes mellitus (T2DM), sponsored by Bærum Sykehus. Started Jan 2002; status: completed.
02
Drugs
metforminrepaglinideglimepiridepioglitazonehuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00133718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133718.